Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers - Advances in Radiation Oncology
Cancers | Free Full-Text | Global Longitudinal Strain in Cardio-Oncology: A Review
Current Oncology | Free Full-Text | Contralateral Neck Irradiation Can Be Omitted for Selected Lateralized Oral Cancer in Locally Advanced Stage
Clinical Oncology | Journal | ScienceDirect.com by Elsevier
Perspectives on the implementation of AI-based solutions for Radiation Oncology – Where are we? – MVision AI
Frontiers | Radiobiology Experiments With Ultra-high Dose Rate Laser-Driven Protons: Methodology and State-of-the-Art
PDF) Single-fraction magnetic resonance guided stereotactic radiotherapy – A game changer?
Frontiers | High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Impact of delivery time factor on treatment time and plan quality in tomotherapy | Scientific Reports
Frontiers | Case report: L5 tomita En bloc spondylectomy for oligometastatic liposarcoma with post adjuvant stereotactic ablative radiotherapy
Provision of personal protective equipment (PPE) during P1 and P2 to... | Download Scientific Diagram
Current Oncology | Free Full-Text | Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review
Complementary Approaches to Lung Cancer Detection in High-Risk Populations | Journal of Clinical Oncology
American Journal of Clinical Oncology - Wikipedia
Cancers | Free Full-Text | The Relationship between Cancer and Dementia: An Updated Review
Current Oncology | Free Full-Text | The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer
Frontiers | Cancer survivorship at heart: a multidisciplinary cardio- oncology roadmap for healthcare professionals
Home Page: Clinical Oncology
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer | npj Breast Cancer
Breast cancer - The Lancet
Predicting cancer outcomes with radiomics and artificial intelligence in radiology | Nature Reviews Clinical Oncology
